Identification of Pulmonary Lung Tumor Resistance 1 QTL Candidates
肺肿瘤抗性1 QTL候选者的鉴定
基本信息
- 批准号:7474739
- 负责人:
- 金额:$ 33.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-07-16 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:A/J MouseAccountingAllelesApoptosisBackcrossingsBiological AssayCandidate Disease GeneCell CycleCell LineCell ProliferationCellsCharacteristicsChromosomes, Human, Pair 11CodeComplementary DNACongenic StrainDNA SequenceDatabasesDevelopmentEnvironmental CarcinogensExhibitsGenesGeneticGenetic HeterogeneityGenetic PolymorphismGenetic Predisposition to DiseaseGenomicsGoalsGrowthHumanIn VitroInbred MouseInbred Strains MiceKnock-in MouseLod ScoreLungLung AdenomaLung NeoplasmsMalignant neoplasm of lungMapsMitotic Cell CycleMouse StrainsMusNamesNude MicePhenotypePredispositionProductionQuantitative Trait LociResistanceRoleSeriesSmokeSusceptibility GeneTumor Suppressor ProteinsVariantadenomabasechemical carcinogencongenicenvironmental agentgene environment interactiongenetic linkagegenetic linkage analysisgenome databasegenome sequencinglung basal segmentlung carcinogenesislung tumorigenesismouse modelneoplastic cellpositional cloningsizetumortumorigenic
项目摘要
DESCRIPTION (provided by applicant): This application will focus on genetic susceptibility to lung adenoma induction to environmental carcinogens. Linkage analysis previously mapped a lung adenoma resistance quantitative trait locus (QTL) named pulmonary adenoma resistance 1 locus or Par1 which is located on mouse chromosome 11. The Par1 locus confers protection against lung adenoma development. Contributed by M. spretus allele, Par1 locus accounts for 23% of lung adenoma resistance phenotype to chemical carcinogens when co-expressed with highly penetrant Pas1 allele of the A/J strain. The goal of this proposal is to identify the Par1 gene, which is responsible for lung adenoma resistance to chemical carcinogens. The Par1 QTL mapping result has been confirmed by the production of congenic strains in which adenoma resistant M. spretus allele was substituted onto the genetic background of the A/J mouse. Next, the Par1 locus will be fine-mapped by progressively reducing the QTL region through the production of sub-congenic mouse strains to narrow it to a size of around 0.2-0.5 cM, which is expected to be small enough for positional cloning. DNA sequences of the entire narrowed region will be obtained through completed mouse genomic databases. New and known genes in the target region will be identified and candidate genes will be sought based on known or deduced function and/or differences in expression between A/J mice and M. spretus mice. Effect of the candidate Par1 genes on tumorigenic and growth characteristics of mouse lung cells will be examined in vitro. The functional role of the candidate Par1 gene in mouse lung carcinogenesis will be evaluated by constructing knock-in mice. The resulting knock-in mice will be subjected to lung carcinogenesis assay to confirm the Par1 gene. The significance of these studies is that they will identify the Par1 gene and facilitate our understanding of genetic basis of lung adenoma induction by environmental carcinogens.
描述(由申请人提供):本申请将集中于对环境致癌物诱导肺腺瘤的遗传敏感性。链接分析先前绘制了一个肺腺瘤抗性定量性状基因座(QTL),称为肺腺瘤抗性1基因座或PAR1,位于小鼠染色体11上。PAR1基因座赋予肺腺瘤发育的保护。 PAR1基因座由M. spretus等位基因贡献,占化学致癌物的肺腺瘤耐药表型的23%,当时与A/J菌株的高渗透率PAS1等位基因共表达时。该提案的目的是识别PAR1基因,该基因负责肺腺瘤对化学致癌物的耐药性。 PAR1 QTL映射结果已通过产生先天性菌株的产生,其中将抗腺瘤的SPRETUS等位基因取代在A/J小鼠的遗传背景上。接下来,通过生产亚综合小鼠应变逐渐减少QTL区域,将其缩小到0.2-0.5 cm左右,预计将其缩小到大约0.2-0.5 cm左右,预计将其缩小到大约0.2-0.5 cm,以缩小QTL区域,预计将其缩小到大约0.2-0.5 cm。整个狭窄区域的DNA序列将通过完成的小鼠基因组数据库获得。将根据已知或推导的功能和/或SPRETUS小鼠的表达差异来鉴定目标区域中的新基因和候选基因。将在体外检查候选PAR1基因对小鼠肺细胞的致瘤和生长特征的影响。候选PAR1基因在小鼠肺癌发生中的功能作用将通过构造敲入小鼠进行评估。由此产生的敲入小鼠将进行肺癌发生测定,以确认PAR1基因。这些研究的意义在于它们将鉴定PAR1基因,并促进我们对环境致癌物诱导肺腺瘤诱导的遗传基础的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MING YOU其他文献
MING YOU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MING YOU', 18)}}的其他基金
IGF::OT::IGF LUNG CANCER CHEMOPREVENTION BY MICRORNA DELIVERY
通过 MICRORNA 递送进行 IGF::OT::IGF 肺癌化学预防
- 批准号:
9356882 - 财政年份:2016
- 资助金额:
$ 33.77万 - 项目类别:
TARGETED, LABEL-FREE PROTEOMIC ANALYSIS OF URINE IN A RAT BLADDER CANCER MODEL
对大鼠膀胱癌模型中的尿液进行有针对性的、无标记的蛋白质组学分析
- 批准号:
8361368 - 财政年份:2011
- 资助金额:
$ 33.77万 - 项目类别:
TARGETED, LABEL-FREE PROTEOMIC ANALYSIS OF URINE IN A RAT BLADDER CANCER MODEL
对大鼠膀胱癌模型中的尿液进行有针对性的、无标记的蛋白质组学分析
- 批准号:
8168722 - 财政年份:2010
- 资助金额:
$ 33.77万 - 项目类别:
Chemoprevention of lung cancer with red ginseng extracts
红参提取物对肺癌的化学预防
- 批准号:
8324234 - 财政年份:2009
- 资助金额:
$ 33.77万 - 项目类别:
TARGETED, LABEL-FREE PROTEOMIC ANALYSIS OF URINE IN A RAT BLADDER CANCER MODEL
对大鼠膀胱癌模型中的尿液进行有针对性的、无标记的蛋白质组学分析
- 批准号:
7953950 - 财政年份:2009
- 资助金额:
$ 33.77万 - 项目类别:
Chemoprevention of lung cancer with red ginseng extracts
红参提取物对肺癌的化学预防
- 批准号:
8133545 - 财政年份:2009
- 资助金额:
$ 33.77万 - 项目类别:
Chemoprevention of lung cancer with red ginseng extracts
红参提取物对肺癌的化学预防
- 批准号:
7936365 - 财政年份:2009
- 资助金额:
$ 33.77万 - 项目类别:
Chemoprevention of lung cancer with red ginseng extracts
红参提取物对肺癌的化学预防
- 批准号:
7777978 - 财政年份:2009
- 资助金额:
$ 33.77万 - 项目类别:
相似国自然基金
签字注册会计师动态配置问题研究:基于临阵换师视角
- 批准号:72362023
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
全生命周期视域的会计师事务所分所一体化治理与审计风险控制研究
- 批准号:72372064
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
会计师事务所数字化能力构建:动机、经济后果及作用机制
- 批准号:72372028
- 批准年份:2023
- 资助金额:42.00 万元
- 项目类别:面上项目
会计师事务所薪酬激励机制:理论框架、激励效应检验与优化重构
- 批准号:72362001
- 批准年份:2023
- 资助金额:28.00 万元
- 项目类别:地区科学基金项目
环境治理目标下的公司财务、会计和审计行为研究
- 批准号:72332002
- 批准年份:2023
- 资助金额:165.00 万元
- 项目类别:重点项目
相似海外基金
Identification of gene variants mediating the behavioral and physiological response to THC
鉴定介导 THC 行为和生理反应的基因变异
- 批准号:
10660808 - 财政年份:2023
- 资助金额:
$ 33.77万 - 项目类别:
Popliteal Pterygium syndrome, IRf6, and the periderm
腘胬肉综合征、IRf6 和周皮
- 批准号:
10727050 - 财政年份:2023
- 资助金额:
$ 33.77万 - 项目类别:
Genetic and Environmental Influences on Individual Sweet Preference Across Ancestry Groups in the U.S.
遗传和环境对美国不同血统群体个体甜味偏好的影响
- 批准号:
10709381 - 财政年份:2023
- 资助金额:
$ 33.77万 - 项目类别:
The role of non-coding variants in Usher disease
非编码变异在亚瑟病中的作用
- 批准号:
10588508 - 财政年份:2023
- 资助金额:
$ 33.77万 - 项目类别:
Decoding the Paradox of DDX41-mutant MDS
解读 DDX41 突变型 MDS 的悖论
- 批准号:
10905168 - 财政年份:2023
- 资助金额:
$ 33.77万 - 项目类别: